Epidemiological Assessment of Leukemia in Kazakhstan, 2003-2012

  • Igissinov, Nurbek (National Center for Neurosurgery) ;
  • Kulmirzayeva, Dariyana (Central Asian Cancer Institute) ;
  • Moore, Malcolm A. (APJCP Editorial Office) ;
  • Igissinov, Saginbek (Central Asian Cancer Institute) ;
  • Baidosova, Gulnara (West Kazakhstan Marat Ospanov State Medical University) ;
  • Akpolatova, Gulnur (Astana Medical University) ;
  • Bukeyeva, Zhanar (Astana Medical University) ;
  • Omralina, Yelvira (Astana Medical University)
  • Published : 2014.08.30


Cancer is a major health problem facing the entire world, and Kazakhstan is not the exception. The aim of this study was to present an epidemiological assessment of leukemia in the population of Kazakhstan during 2003-2012. This descriptive and retrospective study was based on data obtained from all oncological organizations of the whole country. Age standardized incidence rates per 100,000 population for leukemia were calculated. Totally, 6,741 new cases of leukemia were registered in Kazakhstan during the 10 year period. The mean age of patients with leukemia was 48.5. The ASRs for leukemia among men and women were 5.3 and 3.6, respectively (p<0.001). In conclusion, our results showed a high incidence rate of leukemia in Kazakhstan, especially in the north of the country. The incidence of leukemia was significantly higher in males and increased with age. Determining and controlling important risk factors of leukemia may lead to decrease in its burden.


Leukemia;epidemiology;time trends;geographical distribution;Kazakhstan


  1. Belson M, Kingsley B, Holmes A (2007). Risk factors for acute leukemia in children: a review. Environ Health Persp, 115, 138-145.
  2. Baimukhanov SB, Gusev BI, Baimukhanov TS (2002). Radioactivity and Population Health Status around Semipalatinsk Nuclear Test Site. Almaty, part 1, chapter 1, pp. 1-10.
  3. Balasubramaniam G, Saoba SL, Sarhade MN, Kolekar SA (2013). Lifestyle factors including diet and leukemia development: a case-control study from Mumbai, India. Asian Pac J Cancer Prev, 14, 5657-61.
  4. Bhat G, Bhat A, Wani A, et al (2012). Polymorphic variation in glutathione-S-transferase genes and risk of chronic myeloid leukaemia in the Kashmiri population. Asian Pac J Cancer Prev, 13, 69-73.
  5. Bilyalova Z, Igissinov N, Moore M, et al (2012). Epidemiological evaluation of breast cancer in ecological areas of Kazakhstan- -association with pollution emissions. Asian Pac J Cancer Prev, 13, 2341-4.
  6. Campana D, Pui CH (2008). Childhood Leukemia. In 'Abeloff's Clinical Oncology', Abeloff MD, Armitage JO, Niederhuber JE, et al. Churchill Livingstone, 4th Edition, Chapter 96, pp. 1850-72.
  7. Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://, accessed on 22.10.2013.
  8. Glantz SA (2001). Primer of Statistics. 5th edition, McGraw- Hill, New York.
  9. Goldman L, Andrew IS (2012). Goldman's Cecil Medicine: 24th Edition. Section15, pp. 1203-33.
  10. Gordis L (2008). Epidemiology. 4th edition, Elsevier. Chapter 19, 333-347.
  11. Hirabayashi K, Kawano N, Ohtaki M, et al (2008). Health status of radiation exposed residents living near the Semipalatinsk Nuclear Test Site based on health assessment by interview. Hiroshima J Med Sci, 57, 27-35.
  12. Igissinov SI (1974). Method of production and use of maps in oncological practice. Kazakhstan Health, 2, 69-71.
  13. Igissinov S, Igissinov N, Moore MA, Kalieva Z, Kozhakhmetov S (2012a). Epidemiology of esophageal cancer in Kazakhstan. Asian Pac J Cancer Prev, 13, 833-6.
  14. Igissinov N, Nuralina I, Igissinova G, et al (2012b). Epidemiological aspects of morbidity and mortality from cervical cancer in Kazakhstan. Asian Pac J Cancer Prev, 13, 2345-8.
  15. Igissinov N, Zatoskikh V, Moore MA, et al (2013a). Epidemiological evaluation of laryngeal cancer incidence in Kazakhstan for the years 1999-2009. Asian Pac J Cancer Prev, 14, 3969-74.
  16. Igissinov N, Zatoskikh V, Moore MA, et al (2013b). Laryngeal cancer in Kazakhstan - ethnic, age and gender differences over time variation. Asian Pac J Cancer Prev, 14, 7033-8.
  17. Ismail SI, Soubani M, Nimri JM, Al-Zeer AH. (2013). Cancer incidence in Jordan from 1996 to 2009 - a comprehensive study. Asian Pacific J Cancer Prev, 14, 3527-34.
  18. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
  19. Kampen KR (2012). The discovery and early understanding of leukemia. Leukemia Res, 36, 6-13.
  20. Lihodumova IN (2009). Environmental risk assessment of morbidity of North-Kazakhstan region. Barnaul, 18 p.
  21. Longo D, Anthony F, Dennis K, et al (2011). Harrison's Principles of Internal Medicine: 18th Edition. Part 7, pp. 435-70.
  22. Modak H, Kulkarni SS, Kadakol GS, et al (2011). Prevalence and risk of leukemia in the multi-ethnic population of North Karnataka. Asian Pac J Cancer Prev, 12, 671-5.
  23. Novak I, Jaksic O, Kulis T, Batinjan K, Znaor A (2012). Incidence and mortality trends of leukemia and lymphoma in Croatia, 1988-2009. Croat Med J, 53, 115-23.
  24. Peter HW, John MG, Janice PD, Robert AK (2013). Neoplastic Diseases of the Blood, 5th Edition, 2013.
  25. Rajabli N, Naeimi-Tabeie M, Jahangirrad A, et al (2013). Epidemiology of leukemia and multiple myeloma in Golestan, Iran. Asian Pacific J Cancer Prev, 14, 2333-6.
  26. Robert MK, Bonita MD S, Joseph SG, et al (2011). Nelson Textbook of Pediatrics: 19th Edition. Part 22, pp. 489-490.
  27. Salim EI, Moore MA, Bener A, et al (2010). Cancer epidemiology in South-West Asia - past, present and future. Asian Pacific J Cancer Prev, 11 Suppl 2, 33-48.
  28. Sanoff HK, Mitchell BS (2009). Leukemias. In 'Netter's Internal Medicine (2ND)', Runge MS and Greganti AM. W.B. Saunders Elsevier, Health Sciences, p.1332.
  29. Sant M, Allemani C, Tereanu C, et al (2010). Incidence of hematologic malignancies in Europe by morphologic subtype. J Am Soc Hematol, 116, 3724-34.
  30. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
  31. Tahmasby B, Marnani AB, Maleki M, et al (2013). Blood malignancies in Mazandaran Province of Iran. Asian Pacific J Cancer Prev, 14, 1053-6.
  32. Thygesen LC, Nielsen OJ, Johansen C (2009). Trends in adult leukemia incidence and survival in Denmark, 1943-2003. Cancer Causes Control, 20, 1671-80.
  33. Xie WC, Chan MH, Mak KC, Chan WT, He M (2012). Trends in the incidence of 15 common cancers in Hong Kong, 1983- 2008. Asian Pac J Cancer Prev, 13, 3911-6.
  34. Zheng RZ, Zhang QH, He YX, et al (2013). Historical long-term exposure to pentachlorophenol causing risk of cancer--a community study. Asian Pac J Cancer Prev, 14, 811-6.

Cited by

  1. Leukemia in Iran: Epidemiology and Morphology Trends vol.16, pp.17, 2015,
  2. Cancer Incidence and Mortality Data in Aktobe, West Kazakhstan, 2000-2010 vol.16, pp.6, 2015,
  3. Malignant Neoplasm Prevalence in the Aktobe Region of Kazakhstan vol.16, pp.18, 2016,